Over 150 New York Auctions End Today - Bid Now
Over 1350 Total Lots Up For Auction at Three Locations - NJ 04/25, MA 04/30, NJ Cleansweep 05/02

Mike Lobinsky

EOS Imaging appoints new President North America
November 19, 2018
Business Affairs
Mike Lobinsky
Paris, November 5, 2018 - 6 pm CET - EOS imaging (Euronext, FR0011191766 - EOSI - Eligible PEA - PME), the pioneer of orthopedic medical imaging 2D / 3D, announces the change of its leadership effective January 1, 2019.

The Board of Directors, in agreement with Marie Meynadier, Chief Executive Officer of EOS imaging, has decided to change the leadership of the company to strengthen the company's presence in the United States, its largest market, and expand its shareholder base.

The Board has unanimously appointed Mike Lobinsky, who joined the company in August 2017 as President North America, to the position of Chief Executive Officer effective January 1, 2019. Marie Meynadier will continue as Chief Executive Officer of EOS Imaging until December 31, 2018 and thereafter retains a position on the Board of Directors. Also being considered is Mike Lobinsky's nomination to Director of EOS imaging at a subsequent Shareholder General Meeting.

Mike Lobinsky has over twenty years' experience in the medtech industry with senior management roles in sales, marketing, operations and business development in the fields of Orthopedic Robotics, Navigation, Imaging and Implants. He has held leadership positions at Smith and Nephew, Brainlab, Blue Belt Technologies, Stryker and most recently contributed to the acquisition of Blue Belt by S&N prior to joining EOS in 2018.

Marie Meynadier, Chief Executive Officer of EOS Imaging, said, "I have enjoyed working with Mike for over a year. His leadership and knowledge of the industry, combined with his fine understanding of corporate culture, are excellent assets for EOS imaging and I have complete confidence in his ability to continue and accelerate the development of the company. Our North American market is considerable, and Mike will be able to develop it without denying our European roots, relying on the talented management team present in Paris, particularly Eric Maulavé, Chief Operating Officer, to continue to drive global growth. It was an honor and a great pleasure to serve the company and to develop it since its foundation. I am most grateful to the men and women within our staff, to our Directors, shareholders and clinical partners, who contributed to this development over these last years. Our teams can be proud of the work accomplished, and I have full confidence that they will continue to build our success under Mike's leadership."

GĂ©rard Hascoet, Chairman of the Board of Directors of EOS Imaging, commented: "Marie's vision, her energy and her remarkable managerial talent have brought EOS imaging to a stage of excellence and a unique international reputation. Marie has given the company access today to an acceleration opportunity in the United States, which is a new step. She has managed to attract a management team capable of taking up this new challenge and ensure a successful succession. It is rare to be able to apprehend the future in such optimism."

You Must Be Logged In To Post A Comment

 

advertisement

Business Affairs Homepage

Five ways to increase clinical trial diversity through patient engagement
Insights from Catherine Ofori-Atta, senior clinical operations lead at Roche and Sandra Amaro, head of clinical trial diversity at Pfizer
Cardiologist who billed 28 hours of exams in a single day cops to fraud
New Jersey provider admits to almost $2 million in phony claims
ACR cuts workforce 11% citing pandemic impact
45 employees were affected by the downsizing
GE HealthCare's imaging CEO stepping down
Jan Makela will be leaving after more than 17 years with the company
Connecticut patient to receive $14 million after table collapses during imaging exam
Incident took place in 2014 and legal battle began in 2016
Understanding healthcare's big shift toward outpatient facilities from a real estate perspective
New report from JLL sheds light on motives and advantages
STERIS to divest its dental segment to Peak Rock Capital for $787 million
Sale allows company to focus on core markets including healthcare, pharmaceuticals, and medtech
Massive Stark Law settlement underscores continued government scrutiny of health system physician employment arrangements
Insights from Joseph Keillor, healthcare attorney with Baker Donelson
RadNet expands Houston presence with acquisition of six imaging centers
Will rebrand them under the Houston Medical Imaging banner
KARL STORZ enters talks to acquire Asensus Surgical for $95 million
Surgical robot developer is a pioneer in digitizing surgical procedures